# Can GHRP-6 reduce oxidative stress in neonatal hypoxic-ischemic injury?

Canonical source: https://retacompare.com/research/can-ghrp-6-reduce-oxidative-stress-in-neonatal-hypoxic-ischemic-injury

Peptide Longevity Q&A · 2019-09-01


    Research indicates that GHRP-6, through its action on the GHSR-1α receptor, can significantly reduce oxidative stress and neuronal apoptosis following hypoxic-ischemic injury in a rat model. This suggests potential therapeutic implications for conditions involving oxidative damage.

 What the research shows

The study investigated the effects of ghrelin, a ligand for the growth hormone secretagogue receptor-1α (GHSR-1α), on oxidative stress and neuronal apoptosis in a rat model of neonatal hypoxic-ischemic encephalopathy (HIE). In this preclinical study, ten-day-old unsexed rat pups were subjected to hypoxia-ischemia (HI) and treated with recombinant human ghrelin (rh-Ghrelin) administered intranasally at various time points post-injury. The researchers also utilized [D-Lys 3]-GHRP-6, a selective inhibitor of GHSR-1α, and Ex527, to assess the specific pathways involved. Neurological outcomes were measured through behavioral tests, and various biochemical assays were performed to evaluate oxidative stress and apoptosis markers.

 Why it matters for longevity

Oxidative stress is a significant contributor to cellular aging and neurodegenerative diseases. By demonstrating that GHRP-6 can mitigate oxidative stress and neuronal apoptosis, this research highlights a potential pathway through which GHRP-6 may promote neuronal health and longevity. Targeting oxidative damage could be a crucial strategy in extending healthspan and mitigating age-related neurological decline. The findings suggest that interventions like GHRP-6 could be explored further for their potential to enhance resilience against age-related cognitive decline and neurodegenerative diseases.

 Key findings at a glance

GHRP-6 significantly improved neurobehavioral outcomes in a rat model of neonatal HIE.

The treatment reduced markers of oxidative stress and neuronal apoptosis.

GHRP-6 promoted the phosphorylation of AMPK and upregulated Sirt1, PGC-1α, and UCP2.

Neuroprotective effects of GHRP-6 were reversed by GHSR-1α inhibitors.

GHRP-6 may serve as a novel therapeutic target for conditions involving oxidative stress injury.

 How GHRP-6 works (background)

GHRP-6 acts primarily through the GHSR-1α receptor, which is involved in various signaling pathways that regulate cell survival and metabolism. Activation of GHSR-1α leads to the phosphorylation of AMPK, a key energy sensor that promotes cellular energy homeostasis and reduces oxidative stress. Additionally, GHRP-6 enhances the expression of Sirt1, a protein associated with longevity and metabolic regulation, and PGC-1α, which is crucial for mitochondrial biogenesis and function. This multifaceted action of GHRP-6 suggests that it may protect neurons from oxidative damage and apoptosis, potentially contributing to improved longevity and healthspan.

 Safety, caveats, and what we don't yet know

While the research presents promising findings, it is essential to note that the study was conducted in a preclinical model, and the direct applicability to humans remains to be established. Further research is needed to explore the long-term effects of GHRP-6, optimal dosing, and safety profiles in various populations. Additionally, the effects of GHRP-6 on other age-related conditions and its interactions with other longevity interventions require further investigation. The mechanisms underlying its neuroprotective effects also warrant deeper exploration to fully understand the implications for clinical use.

 Bottom line

GHRP-6 has been shown to reduce oxidative stress and neuronal apoptosis in a rat model of neonatal hypoxic-ischemic injury, indicating its potential as a therapeutic agent for conditions related to oxidative damage.

 Related questions

 Does GHRP-6 have neuroprotective effects in aging models?

Research suggests that GHRP-6 may offer neuroprotective benefits by reducing oxidative stress and apoptosis, which could be relevant in aging models experiencing neurodegeneration.

 How does GHRP-6 interact with other longevity peptides?

GHRP-6 may synergize with other longevity peptides by enhancing mitochondrial function and reducing inflammation, potentially leading to improved healthspan and longevity when used in combination.

 What are the implications of GHRP-6 for age-related diseases?

The ability of GHRP-6 to mitigate oxidative stress and neuronal apoptosis suggests that it could have significant implications for treating age-related diseases, particularly neurodegenerative disorders.

 Source: PubMed · Free Radic Biol Med · published 2019-09-01.

## Sources

- PubMed · Free Radic Biol Med: https://pubmed.ncbi.nlm.nih.gov/31279091/